A federally funded study is coming to Minnesota to determine if whole genome sequencing at birth can reduce childhood diseases and deaths while satisfying growing concerns over genetic privacy and ...
As genetic testing and genome sequencing become part of everyday healthcare, questions about privacy, consent, and data security are more urgent than ever. Sensitive DNA information can reveal not ...
Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted ...
A study from Columbia University  reports a major advance in understanding how interactions between human and viral genomes shape disease risk. The research found that variations in the Epstein–Barr ...
Despite advances, whole genome sequencing — and with it the promise of early, life-altering therapies — still isn’t a routine part of care for most newborns. Many babies enter the world with silent ...
Sequencing nearly half a million genomes, researchers show that most additive genetic influences on height, lipids, and other complex traits are now directly measurable, while pinpointing ultra-rare ...
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over ...